Communications - NISCAIRnopr.niscair.res.in/bitstream/123456789/49358/1/IJCA 22A... · 2019. 7....
Transcript of Communications - NISCAIRnopr.niscair.res.in/bitstream/123456789/49358/1/IJCA 22A... · 2019. 7....
Indian Journal of ChemistryVol. 22A, August 1983, pp. 639-640
Communications
Wavefunction Oriented Index asPossible Link between K-Region,Bay-Region, Distal Bay-Region &
Carcinogenicity of~ethylbenz[a]anthracenes
S N00R MOHAMMAD
Molecular Biology and Biophysics Program,Department of Physics and Meteorology,
Indian Institute of Technology, Kharagpur 721302
Received 4 April 1983; accepted 6 June 1983
A wavefunction oriented index has been devised to study the roleof specific molecular regions, viz. K-, L-, bay- and distal bay-regionsin the carcinogenic activity ofmethylbenz[a]anthracenes (MBAs).In contrast to experimental reports, the K-region of the compoundsplays a key role, of course indirectly, in determining the carcinogenicpoten y and the bay-region metabolic activation of various MBAs.
Depending on the specific substitution site, a methylsubstituent usually alters the biological activity+? of apolycyclic aromatic hydrocarbon (PAH). Themolecular basis for this variation of biological activityis not yet properly understood. Pullman and Pullman 'have demonstrated that K- and L-region peculiaritiesof the electronic characteristics related to physico-chemical properties of a parent PAH dictate much ofthe carcinogenic behaviour of a compound. The K-region is typified by 9, lO-bond of a phenanthrene andthe L-region by 7, 12-bond ofa benz[aJanthracene. Inorder to be carcinogenic, a compound must have areactive K-region. If there is an L-region the latter mustbe reasonably unreactive. According to a recenthypothesis" PAHs are known to be metabolized bymammalian microsomal drug-metabolizing enzymesystems in a highly stereoselective manner ':". Jerinaand coworkers 7 ascribe this metabolic activation to theinduction of electronic changes that result in anenhanced carcinogenic activity through the bay-regionof the parent compound. The metabolic transforma-tion appears to follow a pathway: PAH-+epoxide-+dihydrodiol-+ bay-region dihydrodiol-epoxide.Jerina et al. further observed that the calculated bay-region delocalization energy which forms the basis oftheir bay-region theory nicely correlates with thePullmans' K-region index determined by a combi-nation of the Hiickel localization energy. In recentexperiment: 8 the K-region is hardly found to mediatethe binding of a carcinogen to DNA. However, theabove correlation demonstrates, if not directly, thatthe K-region plays some indirect role in thecarcinogenesis of PAH~. The present investigation is
I
aimed at elucidating the relative role of the K- and bay-regions and of the substitution of the methyl grouptowards cancer inducing activities of benz[aJanthra-cene. The reactivity index, RAJ..n), defined from SCF-MO wavefunctions of quantum mechanical molecularorbital method, MINDO/3 of Bingham et al:", isemployed for the purpose. The index corresponding tobond A-B is given by
RAJ..n) = f C~k + C~k + 2CakCbkSab
k= I Ekk
where: (i)a, b = the n(z) atomic orbitals correspondingto atoms A and B. respectively; (ii)k = an occupiedmolecular orbital irrespective of whether it is tt- 01 a-orbital; (iii)Cak = coefficient of n(z) atomic orbital ofatom A in the occupied molecular orbital k; (iv) SAB
=overlap integral of n(z) atomic orbitals, a am! b ofatoms A and B respectively; (v) Ekk = energy of theoccupied molecular orbital k; and (vi)n = sum of alloccupied n and a-molecular orbitals.
The values of RAJ..n) for K-region, bay-region anddistal bay-region A-B double bonds of various MBAsare presented in Table I. The values correspond toMBA geometries determined by stepwise optimizationprocedure described in detail in our earlierinvestigation I 0. The least negative values of RAJ..n) forall the three regions indicate that 7-MBA is the mostcarcinogenic in the series. These values for similarregions of other MBAs are in conformity with theexperimental values II given in the last column ofTable l . For example, on the basis of RAB(n) for the K-
Table I - Comparison of Bond Reactivity with ExperimentalCarcinogenic Potency of Methylbenz[aJanthracenes
Location - RAfin) Carcino*of themethylgroup
K-region(5,6-bond)
Bay-region(1,2-bond)
Distalbay-region(3,4-bond)
0.44140.45020.4'3210.45370.44040.39460.36910.39520.40590.40630.40140.3820 ++
I23456789
10II12
1.24211.2~ 121.23131.29391.33051.13781.01951.10341.12921.15521.12801.0383
0.48360.51390.50620.51660.49940.43730.40840.43890.45030.45290.44720.4182
++++++++±
"Taken from reference II.
639
\\
INDIAN J. CHEM., VOL. 22A. AUGUST 1983
region 12-,8-, and 6-MBAs are the most carcinogeniccompouncs next to 7-MBA of the series. The results inTable 1 indicate that K-region is as important as thebay-region or the distal bay-region in impartingcarcinogenicity to MBAs.
Both activation and detoxification pathways occurin PAHs and the biological character of the resultantproduct depends on a balance between the two. Theproducts are the metabolites of the metabolites. So it islikely that K-region metabolites which are formed inthe initial/intermediate stage undergo subsequentdetoxification due to charge delocalization presum-ably to the bay-region or the distal bay-region of acompound. This is why in the eyes of experimentaliststhe K-region is not directly involved in thecarcinogenicity of a PAH. Nevertheless it is the mostimportant factor in the phenomenon in thatelectrophilic character of the ultimate metabolitedepends on how much charge transfer from the K-region is possible in a compound.
The author thanks the CSIR, New Delhi for partlysupporting the project. He is grateful toProf'S T H Abidi for encouragement, to Dr Hasan
640
I
Mukhtar for discussions, to Dr S P Sinha for help incomputer calculation, and to M Mainuddin Khan fora careful typing.
ReferencesI Stevenson J L & Yon Haam E. Am Ind Hyg Assoc J, 26 (1965)
475.2 Iyer R P, Lyga J W. Secrist(IIO J A, Daub G H & Siaga T J,
Cancer Res, 40 (1980) 1073.3 Pullman A & Pullman B, Adz'. Cancer Res. 3 (1955) 117.4 Miller J A, Cancer Res, 30 (1970) 559.5 Sims P & Grover P L, Adv Cancer Res. 20 (1974) 165.6 Yang S K. McCourt D W, Roller P P & Gelboin H V, Proc natl
Acad Sci (USA), 73 (1976) 2594.7 Jerina D M, Lehr R E, Yagi H, Hernandez 0, Dansette P M,
WislockiPG, Wood A W,Chang RL, Levin W &Conney AH, in in vitro metabolic activation in mutagenesis testing,edited by F J de Sarres, J R Fouts, J R Bend & R M Philpot(Elsevier-North Holland, Amsterdam) 1976, 159.
8 Phillips D & Sims P, in Chemical carcinogens and DNA, Yol IIedited by P L Grover, (CRC Press, Florida) 1979,29.
9 Bingham RC, Dewar M J S& Lo D H, JAm chem Soc, 97(1975)1285.
10 Noor Mohammad S, Hopfinger A J & Bickers D R, J TheoretBioi, (In press).
II Loew G, Poulsen M T. Ferrell J & Chaet D, Chem-BiolInteractions, 31 (\ 980) 319.